Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter To Editor
2006:72:6;456-457
doi: 10.4103/0378-6323.29348
PMID: 17179627

Dapsone-induced agranulocytosis in a patient of leprosy

M Mishra, R Chhetia
 Department of Skin and VD, S.C.B. Medical College and Hospital, Cuttack, India

Correspondence Address:
R Chhetia
Room No. 63, Postgraduate Hostel, S.C.B. Medical College Campus, Cuttack - 753 007
India
How to cite this article:
Mishra M, Chhetia R. Dapsone-induced agranulocytosis in a patient of leprosy. Indian J Dermatol Venereol Leprol 2006;72:456-457
Copyright: (C)2006 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Agranulocytosis is a rare but fatal complication of dapsone and should be diagnosed early and treated accordingly as early measures can be life-saving for the patient. Dapsone is the prototype of sulfones. It is used as a primary drug for leprosy[1] and is also used in several inflammatory dermatoses like dermatitis herpetiformis, erythema elevatum diutinum, acne conglobata, bullous lesions in lupus erythematosus and infections like actinomycetoma, P. carinii pneumonia and falciparum malaria.[2],[3]

The adverse profile of dapsone includes hemolysis and methemoglobinemia which are usually pharmacologic at doses of> 50 mg/day. Other side-effects are peripheral neuropathy, hepatitis, sulfone syndrome and rarely, hypoalbuminemia and psychosis.

Agranulocytosis is a rare complication but very serious toxic effect of the sulfones.[1] It has been reported to occur in 0.2-0.4% of patients treated with dapsone.[4] It is reported rarely with dapsone when used alone and is more common when dapsone is used with other agents in the prophylaxis of malaria.

A 25-year-old man presented to us with an erythematous plaque over the left eye since four months. Routine blood investigations were normal. Skin biopsy showed features of borderline tuberculoid leprosy. Skin smear revealed bacteriological index of 1+. Based on the above findings, the patient was categorized as borderline tuberculoid leprosy with Type I reaction with facial nerve involvement and was started on multidrug therapy and daily 60 mg of prednisolone. The patient presented again with high fever, tachypnea, hypotension, pharyngeal congestion, dyspnea, cough, and lymphadenopathy (cervical, inguinal, axillary). Chest examination revealed bilateral coarse crepitations over both lower lungs. There were a few purpuric cutaneous lesions over the right upper limb. Blood culture showed Staphylococcus aureus .

Chest X-ray revealed bilateral lower lobe consolidation. Total count was 700/cmm with peripheral smear showing agranulocytosis. Patient was diagnosed as a case of pneumonia superimposed over agranulocytosis and was transferred to medicine ICU. He was treated with vasopressors, Linezolid (600 mg IV 12 hourly) and amikacin (15 mg/kg) and was given granulocyte colony stimulating factor (G-CSF) in a dose of 5 µg/kg. Granulocyte count became normal after seven days of treatment. Treatment with G-CSF was continued for a total of nine days. Patient′s condition improved rapidly after starting G-CSF and he was discharged later.

Agranulocytosis is an acute condition where there is a sudden drop in white cell production leaving the body susceptible to bacterial invasion and septicemia.[6] It is reported to occur in 0.2-0.4% of patients treated with dapsone. Though reversible, the condition can be fatal due to the occurrence of septicemia or infections.

In the majority of cases, its occurrence is due to sensitization to the drug which depresses the formation of granulocytes in the bone marrow.[5] The mechanism postulated for the sensitization is the formation of hydroxylamine, the toxic metabolite of dapsone which is also responsible for methemoglobinemia and hemolysis.[6] Another possible mechanism being the formation of antibodies for neutrophil progenitors in the bone marrow and the resultant destruction producing agranulocytosis.[6] Agranulocytosis due to dapsone is not dose-related and when severe, can also involve platelets.[3]

Neutropenia is noticed earliest at three weeks and the onset almost always occurs within three months,[3] Fever and ulcerating pharyngitis, pallor, in a patient on the first few months of dapsone should be taken as warning symptoms and agranulocytosis should be excluded in such cases.[7]

Dapsone can produce agranulocytosis in other conditions besides dermatitis herpetiformis like leprosy, linear IgA dermatosis, cicatricial pemphigoid, rheumatoid arthritis, leukocytoclastic vasculitis, and even when given for malaria prophylaxis,[3],[6],(8) The rare nature of this side-effect and associated drugs like prednisolone account for the late detection of this complication and the resulting fatality.

In our patient, early treatment with antibiotics and G-CSF accounted for the survival of the patient. It is recommended that a patient should be cautioned about the development of infection and fever during the initial part of dapsone treatment.[2] A review shows this side-effect to be population-sensitive.[5] To detect the complication early, a leukocyte count with a differential and hemoglobin levels should be done weekly for the first month of therapy, twice monthly for the next two months, and periodically thereafter.[2] Liver and renal function tests are also conducted, before therapy and periodically later. However, the rarity of this complication makes such testing difficult to follow as a routine.

Fatality in different case reports has been 20%.[5] This fatal condition should be diagnosed early and treated accordingly as early measures can be life-saving for the patient.

References
1.
Jacobson RR. Treatment of Leprosy. In: Hastings RC, editor. Leprosy. 2nd ed. London: Churchill Livingstone; 1994. p. 317-49.
[Google Scholar]
2.
Katz SI. Sulphones. In : Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith L, Katz S, editors. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York: Mc Graw Hill; 2003. p. 2388-91.
[Google Scholar]
3.
Jacobus DP. Dapsone. In: Drug therapy in dermatology. Millikan LE, editor. Marcel Dekker Inc: 2000. p. 445-75.
[Google Scholar]
4.
Hornsten P, Keisu M, Wiholm BE. The Incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990;126:919-22.
[Google Scholar]
5.
Banfield N. Agranulocytosis and Dapsone in Vietnam. Available from:www.hotkey.net.au/~marshalle/medical/agrandapsone.html.
[Google Scholar]
6.
Woodbury GR Jr, Fried W, Ertle JO, Malkinson FD. Dapsone associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis. J Am Acad Dermatol 1993;28:781-3.
[Google Scholar]
7.
Bhat RM, Radhakrishnan K. A case report of total dapsone induced agranulocytosis in an Indian mid-borderline leprosy patient. Lepr Rev 2003;74:167-70.
[Google Scholar]

Fulltext Views
373

PDF downloads
51
Show Sections